Encurtamento do tratamento e controle da recidiva na tuberculose pulmonar medicamentosa: uma meta-análise em rede de ensaios randomizados
InfectologiaResumo original em inglês
O que aconteceu
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251267175.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Treatment shortening and relapse control in drug-susceptible pulmonary tuberculosis: a network meta-analysis of randomized trials
Fengjie Tang, Juan Li, Qihuan Ma, Shasha Tao, Ling Zhou, Yanmei Feng
Descritores MeSH
- Antitubercular Agents
- Tuberculosis, Pulmonary
- Drug Therapy, Combination
- Humans
- Mycobacterium tuberculosis
- Recurrence
- Randomized Controlled Trials as Topic
- Adolescent
- Treatment Outcome
- Adult
Veja também
Estudos relacionados
- Radiological Resolution of Pulmonary Lesions among Drug-resistant Tuberculosis Patients following Bedaquiline-containing Regimen Therapy: A Meta-analysis of Randomized Clinical Trials
- Efficacy & safety of high-dose rifampicin in pulmonary tuberculosis: A systematic review & meta-analysis
- Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
- Executive Summary: Clinical Practice Guidelines on the Management of Resistant Tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
- Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis
- Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial